News

Starting the diabetes drug metformin within 90 days of SARS-CoV-2 infection decreased the risk for developing long COVID by ...
Eli Lilly and Co. (NYSE:LLY) is one of the best beginner stocks to buy, according to analysts. On September 17, the company announced that its diabetes medication, Mounjaro, delivered positive results ...
Obesity is one of the most stubborn health challenges of our time, linked with diabetes, heart disease, sleep problems, and shortened lifespans. Doctors have long sought treatments that not only help ...
A NEW test that can help predict how people will respond to weight loss medications, such as weight loss jabs, has been developed my researchers. The test estimates an individual’s calories ...
Despite some spaces still viewing body size as a good indicator of health, new research has shown that being underweight could actually be worse for you than obesity.
A U-shaped association exists between BMI and the risk for liver stiffness in older adults, with both lower and higher BMI ...
Researchers at Washington University School of Medicine in St. Louis have identified a novel way brown fat—an energy-burning ...
An investigational small-molecule, nonpeptide oral GLP-1 receptor agonist significantly reduced weight in adults with obesity in the randomized ATTAIN-1 trial. At week 72, orforglipron at multiple ...
Researchers found that overweight individuals, as well as some obese individuals, were no more likely to die than individuals ...
In the U.S., the average woman's waist size is about 38.5 inches, which is above the 35-inch threshold that health experts ...
Researchers used drug-target Mendelian randomization to test whether genetically proxied activation of GLP1R and GIPR ...
A new study suggests higher doses of popular weight loss jabs are ‘safe’ and could be offered soon to help people shed more ...